Buprenorphine
Buprenorphine is a pharmaceutical drug with 172 clinical trials. Currently 10 active trials ongoing. Historical success rate of 89.7%.
Success Metrics
Based on 130 completed trials
Phase Distribution
Phase Distribution
35
Early Stage
59
Mid Stage
60
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
87.8%
130 of 148 finished
12.2%
18 ended early
10
trials recruiting
172
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of Brenipatide in Participants With Opioid Use Disorder
Examining Analgesic Synergy and Efficacy in Trauma Care
Rapid Antidepressant Improvement Secondary to Excitatory Brain Responses
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Acceptability and Feasibility of Extended-Release Subcutaneous Buprenorphine on a Mobile Pharmacy Clinic
Clinical Trials (172)
A Study of Brenipatide in Participants With Opioid Use Disorder
Examining Analgesic Synergy and Efficacy in Trauma Care
Rapid Antidepressant Improvement Secondary to Excitatory Brain Responses
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Acceptability and Feasibility of Extended-Release Subcutaneous Buprenorphine on a Mobile Pharmacy Clinic
Maternal Brain Imaging in Opioid Use Disorder
Onsite Buprenorphine Treatment at Syringe Exchange Programs
Identifying Optimal Buprenorphine Dosing for Opioid Use Disorder Treatment and Prevention of Overdose
Oral Buprenorphine as a Novel Low-dose Induction Strategy for Opioid Use Disorder
Rapid Outpatient Low-dose Initiation of Buprenorphine for OUD With Fentanyl Use
Add-on Buprenorphine at Analgesic Doses for the Treatment of Severe Suicidal Ideas During a Major Depressive Episode
Standard Versus High Dose ED-Initiated Buprenorphine Induction
Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer Patients
Drug-Drug Interaction and Safety of AZD4041 Study (Part 1) and Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AZD4041 Study in Opioid Use Disorder (Part 2).
Opiate Suicide Study in Patients With Major Depression
HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis
The Effect of Buprenorphine Continuation for Patients With Opioid Use Disorder
Optimal Treatment of Veterans With PTSD and Comorbid OUD
Psychopharmacological Treatment of Emotional Distress
Extended-release Pharmacotherapy for Opioid Use Disorder
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 172